chevron-down Created with Sketch Beta.

Program Audio Collection

The Return of the CVRs in Pharma, Biotech, and Life Sciences Deals

Evgenia Emilova Hochenberg, Jonathan Davis, Adam H Golden, and Saee Mona Muzumdar

Jump to:

2023 saw a record use of CVRs in pharma, biotech, and life sciences M&A deals. The program will review the key terms in CVRs in deals announced in 2023 and the key issues that arise in the negotiation of CVR agreements.


The content of this program does not meet requirements for continuing legal education (CLE) accreditation. You will not receive CLE credit for participating.